01 4Travoprost Group
Main Therapeutic Indication : Ophthalmology
Currency : USD
2016 Revenue in Millions : 619
2015 Revenue in Millions : 631
Growth (%) : -2
Main Therapeutic Indication : Ophthalmology
Currency : USD
2017 Revenue in Millions : 589
2016 Revenue in Millions : 619
Growth (%) : -5
Main Therapeutic Indication : Ophthalmology
Currency : USD
2018 Revenue in Millions : 517
2017 Revenue in Millions : 589
Growth (%) : -12%
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 433
2018 Revenue in Millions : 517
Growth (%) : -16
LOOKING FOR A SUPPLIER?